Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro

Although thrombomodulin alfa (TM alfa), recombinant human soluble thrombomodulin, exerts antithrombogenic effects through activated protein C (APC), clinical trials suggested that TM alfa has a lower bleeding risk than does recombinant human APC. To address the mechanism explaining this difference,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Kosuke, Tawara, Shunsuke, Tsuruta, Kazuhisa, Hoppensteadt, Debra, Fareed, Jawed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714727/
https://www.ncbi.nlm.nih.gov/pubmed/29683037
http://dx.doi.org/10.1177/1076029618770274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714727/
https://www.ncbi.nlm.nih.gov/pubmed/29683037
http://dx.doi.org/10.1177/1076029618770274

Ejemplares similares